Literature DB >> 17659766

The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic complications.

W S Chan1, M E Dixon.   

Abstract

Since its development over 25 years ago, the use of assisted reproductive technology (ART) is on the increase. Along with its use, are also reports of thromboembolic complications (TEC); these events could resulted in significant maternal morbidity and even mortality. In this article, we reviewed the general principles of ART. We also performed a search of all published cases of TEC associated with ART, and summarized the results of studies investigating underlying hemostatic changes with ART. The goal of this article is to provide non-fertility specialists an understanding of ART, so as to better manage TEC when they occur in predisposed patients. The most common ART procedure performed today, is in-vitro fertilization-embryo transfer (IVF-ET). The process of IVF involves the use of exogeneous hormones to achieve cycle control, stimulate the ovaries, and support implantation. During this process, supraphysiological estradiol levels can result. One major complication of this intervention, ovarian hyperstimulation syndrome (OHSS), can be associated with both arterial and venous thrombotic complications. These events (especially venous thrombosis) have also been reported to occur weeks after OHSS has resolved; and they can present in unusual sites (upper extremities) resulting in treatment challenges. From current available studies, it is clear that with ovarian stimulation, both the coagulation and fibrinolytic systems are activated. This activation appears to be exaggerated and prolonged with the development of OHSS. Whether these changes are sufficient by themselves to explain the occurrence of TEC is yet unknown. Future studies should be focused on defining the frequency and risk factors of these complications; provide a closer examination of the resultant changes in the coagulation cascade during ART, OHSS and early pregnancy; and investigating the appropriate treatment and thromboprophylaxis for patients undergoing a procedure considered "elective".

Entities:  

Mesh:

Year:  2007        PMID: 17659766     DOI: 10.1016/j.thromres.2007.05.023

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  21 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report.

Authors:  Serena Dovey; Lakshmanan Krishnamurti; Joseph Sanfilippo; Sriya Gunawardena; Patricia Mclendon; Mary Campbell; Sandra Alway; Brenda Efymow; Clarisa Gracia
Journal:  J Assist Reprod Genet       Date:  2012-01-05       Impact factor: 3.412

Review 3.  Upper extremity deep venous thrombosis and pulmonary embolus after ovarian hyperstimulation.

Authors:  Anne Catherine Miller Cramer; Anna Warszawa McLean; Jalil Ahari
Journal:  BMJ Case Rep       Date:  2016-08-16

4.  Ovarian hyperstimulation syndrome as a cause of acute limb ischemia.

Authors:  Paige Williams; Clifford Buckley
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-11-15

Review 5.  Imaging of complications following treatment with assisted reproductive technology: keep on your radar at each step.

Authors:  Sitthipong Srisajjakul; Patcharin Prapaisilp; Sirikan Bangchokdee
Journal:  Abdom Radiol (NY)       Date:  2021-09-18

6.  The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization.

Authors:  Kathleen E Brummel-Ziedins; Matthew Gissel; Charles Francis; John Queenan; Kenneth G Mann
Journal:  Thromb Res       Date:  2009-03-17       Impact factor: 3.944

7.  Venous thromboembolism in pregnancy.

Authors:  Marcelo P Villa-Forte Gomes
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-04

Review 8.  Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis.

Authors:  Kelly Comerford Wormer; Ayesha A Jangda; Farah A El Sayed; Katherine I Stewart; Sunni L Mumford; James H Segars
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-03-19       Impact factor: 2.435

Review 9.  Thrombophilia and assisted reproduction technology-any detrimental impact or unnecessary overuse?

Authors:  Baris Ata; Bulent Urman
Journal:  J Assist Reprod Genet       Date:  2016-07-16       Impact factor: 3.412

10.  Fertility preservation before hematopoetic stem cell transplantation: a case series of women with GATA binding protein 2 deficiency, dedicator of cytokinesis 8 deficiency, and sickle cell disease.

Authors:  Alexandra Aserlind; Anne Martini; Jiawen Dong; Jessica Zolton; Olivia Carpinello; Alan DeCherney
Journal:  F S Rep       Date:  2020-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.